Search Medicilon

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

AACR 2026

【Case Study】Route, Solid-State, and Impurity Optimization (Small-Molecule API)

Contact Medicilon

Name(Required)
Address(Required)